Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris

This is an open-label, multi-center study to be conducted in the United States. The study
will examine the change in lesion count in subjects using Epiduo® Gel Pump (once daily) in
conjunction with Cetaphil® DermaControl™ Foam Wash (twice daily) and Moisturizer SPF 30
(once daily). Subjects with a clinical diagnosis of mild or moderate acne who are eligible
for treatment with Epiduo® in accordance with the currently approved product labeling and
who meet other inclusion/exclusion criteria are to be enrolled in the study and receive the
study products for 8 weeks. Efficacy and safety assessments include: complete lesion counts,
cutaneous irritation assessment, end of study treatment questionnaire, photographic
evaluation for oiliness, skin tone, and P Acnes, hydration assessment, barrier function
assessment, treatment compliance, and adverse event assessment.